TCM product approved for sale in Singapore
By Zhang Yu in Shijiazhuang |
chinadaily.com.cn |
Updated: 2020-05-07 15:56
Share
Share - WeChat
Applications for registration in more countries are underway, including countries in the Middle East, Africa and Latin America, the company said.
Lianhua Qingwen was recommended in four versions of a treatment plan from the National Health Commission for treating COVID-19, the pneumonia associated with the novel coronavirus.
On April 12, the National Medical Products Administration approved adding mild symptoms of COVID-19 as indications for which Lianhua Qingwen is effective.
- Year-ender: Revisiting the shared memories of 2025
- Xi's article on implementing guiding principles of key CPC plenum to be published
- Military drills necessary and justified, mainland official says
- In six decades, Xizang's civil aviation soars to new heights
- Bridge celebrated as engineering marvel opens in Henan
- Through six landmark cases, top court strengthens protections for migrant workers
